150
Participants
Start Date
January 31, 2009
Primary Completion Date
October 31, 2009
Study Completion Date
November 30, 2009
AR9281
AR9281 taken in BID dosing regimen for 28 days
AR9281
AR9281 taken in TID dosing regimen for 28 days
Placebo
Placebo taken in BID dosing regimen for 28 days
Placebo
Placebo taken in TID dosing regimen for 28 days
Arete Investigational site, Marietta
Arete Investigational site, Port Orange
Arete Investigational site, Jacksonville
Arete Investigational site, DeLand
Arete Investigational site, Pembroke Pines
Arete Investigational site, Miami
Arete Investigational site, Tampa
Arete Investigational site, Largo
Arete Investigational site, Bradenton
Arete Investigational site, New Port Richey
Arete Investigational site, Muscle Shoals
Arete Investigational site, Mobile
Arete Investigational site, Louisville
Arete Investigational site, Marion
Arete investigational site, Mount Gilead
Arete Investigational site, Cincinnati
Arete Investigational site, Cincinnati
Arete Investigational site, Paw Paw
Arete Investigational site, Addison
Arete Investigational site, Oklahoma City
Arete Investigational site, Dallas
Arete Investigational site, San Antonio
Arete Investigational site, Austin
Arete Investigational site, Orem
Arete Investigational site, Las Vegas
Arete Investigational site, Mission Hills
Arete Investigational site, Anaheim
Arete Investigational site, Concord
Arete Investigational site, Eugene
Arete Investigational site, Brockton
Lead Sponsor
Arete Therapeutics
INDUSTRY